Eisai Joins PROTAC Club Through New Oncology Collab
Japanese firm joins increasing global interest in PROTAC approach to cancer as it links with UK university for drug discovery collaboration.
Japanese firm joins increasing global interest in PROTAC approach to cancer as it links with UK university for drug discovery collaboration.